| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 01/02/2003 | US20030003080 Reovirus for the treatment of cellular proliferative disorders |
| 01/02/2003 | US20030000518 Delivery of nonsteroidal antiinflammatory drugs through an inhalation route |
| 01/02/2003 | EP1271146A1 Method and composition of cellular reprogramming |
| 01/02/2003 | EP1270737A1 Preincubation assay method |
| 01/02/2003 | EP1270585A1 Peptide derivative |
| 01/02/2003 | EP1270580A1 Antimicrobial acesulfame complexes, their preparation and their use |
| 01/02/2003 | EP1270575A1 Novel crystal form of pyrrolidylthiocarbapenem derivative |
| 01/02/2003 | EP1270570A1 Amide compounds and use thereof |
| 01/02/2003 | EP1270560A1 Hiv replication inhibiting pyrimidines |
| 01/02/2003 | EP1270017A1 Drugs for the diagnosis of tissue-reproductive activity or the treatment of proliferative diseases |
| 01/02/2003 | EP1270016A1 Aids virus vaccine with the use of sendai virus vector |
| 01/02/2003 | EP1270009A1 Antiviral agent containing a combination of calcium salts of organic (fish and shells) and of mineral source |
| 01/02/2003 | EP1270005A2 Formulation comprising amoxicillin and an organic acid |
| 01/02/2003 | EP1269997A1 Unit dosage comprising amoxicillin and clavulanate |
| 01/02/2003 | EP1269996A1 Unit dosage comprising amoxycillin and clavulanate |
| 01/02/2003 | EP1269196A1 Method of screening for inhibitors of osteopontin |
| 01/02/2003 | EP1269180A1 Methods for screening and identifying pathogen virulence factors |
| 01/02/2003 | EP1268844A1 Modulating production of pneumococcal capsular polysaccharide |
| 01/02/2003 | EP1268839A1 Beta-glucans from filamentous fungi |
| 01/02/2003 | EP1268822A2 Recombinant iron uptake proteins |
| 01/02/2003 | EP1268802A2 Beta-like glycoprotein hormone polypeptide and heterodimer |
| 01/02/2003 | EP1268787A2 Human tap-like protein (transporter associated in antigen processing/presentation) |
| 01/02/2003 | EP1268783A2 Anti-angiogenic and anti-tumor properties of matin and other laminin domains |
| 01/02/2003 | EP1268781A2 G12l, a gene associated with the thermal response |
| 01/02/2003 | EP1268774A2 Identification of essential genes in prokaryotes |
| 01/02/2003 | EP1268773A1 Immune system-related polynucleotides, polypeptides, and antibodies |
| 01/02/2003 | EP1268764A2 Method for obtaining nucleic acids from an environment sample |
| 01/02/2003 | EP1268759A2 Genes of il-12p40 subunit mutated for improving the activity of il-12 and use thereof for dna vaccine adjuvant |
| 01/02/2003 | EP1268750A1 Improved methods to isolate, identify, quantify, and propagate chicken infectious anemia virus and high titer vaccine |
| 01/02/2003 | EP1268746A2 PRODUCTION OF TcR GAMMA DELTA T CELLS |
| 01/02/2003 | EP1268559A1 Glycosaminoglycans derived from the k5 polysaccharide having high anticoagulant and antithrombotic activity and process for their preparation |
| 01/02/2003 | EP1268549A2 Method of identifying inhibitors of tie-2 |
| 01/02/2003 | EP1268530A1 Hepatitis b core antigen fusion proteins |
| 01/02/2003 | EP1268529A2 Immuno-reactive peptide ctl epitopes of human cytomegalovirus |
| 01/02/2003 | EP1268525A2 Macrocyclic ns3-serine protease inhibitors of hepatitis c virus comprising n-cyclic p2 moieties |
| 01/02/2003 | EP1268523A2 Binding compounds for cc chemokine receptor 5 and methods for identifying them |
| 01/02/2003 | EP1268521A1 Receptor-binding compounds and methods for identifying them |
| 01/02/2003 | EP1268520A2 Receptor-binding compounds and methods for identifying them |
| 01/02/2003 | EP1268519A2 Inhibitors of serine proteases, particularly hepatitis c virus ns3 protease |
| 01/02/2003 | EP1268504A1 Nucleoside compounds and uses thereof |
| 01/02/2003 | EP1268487A1 Tricyclic protein kinase inhibitors |
| 01/02/2003 | EP1268481A2 Kinase inhibitors as therapeutic agents |
| 01/02/2003 | EP1268475A1 Novel benzosultam oxazolidinone antibacterial agents |
| 01/02/2003 | EP1268474A2 Substituted 1,3-thiazole compounds, their production and use |
| 01/02/2003 | EP1268471A1 N-heterocyclic derivatives as nos inhibitors |
| 01/02/2003 | EP1268455A2 Piperazine derivatives |
| 01/02/2003 | EP1268443A1 2-hydroxy-mutilin carbamate derivatives for antibacterial use |
| 01/02/2003 | EP1268442A2 Crystalline pharmaceutical |
| 01/02/2003 | EP1268437A1 Inhibitors of protein kinases |
| 01/02/2003 | EP1268431A1 3-cyanoquinolines,3-cyano-1,6-naphthyridines, and 3-cyano-1,7-naphthyridines as protein kinase inhibitors |
| 01/02/2003 | EP1268425A2 Carbamate caspase inhibitors and uses thereof |
| 01/02/2003 | EP1268420A1 Chemokine receptor antagonists |
| 01/02/2003 | EP1268419A1 Pyrrolidine derivatives useful as bax inhibitors |
| 01/02/2003 | EP1268418A1 Pharmaceutically active pyrrolidine derivatives as bax inhibitors |
| 01/02/2003 | EP1268414A1 Ceramide derivatives and method of use |
| 01/02/2003 | EP1268407A1 Propenecarboxylic acid amidoxime derivatives, a process for the preparation thereof, and pharmaceutical compositions containing the same |
| 01/02/2003 | EP1267938A1 Proteins for use as carriers in conjugate vaccines |
| 01/02/2003 | EP1267932A1 Anti-infective active substance combinations and the use thereof for the topical treatment of fungus diseases of toe and finger nails |
| 01/02/2003 | EP1267930A1 Cross-reactive displacing antibodies from collagen-binding proteins and method of identification and use |
| 01/02/2003 | EP1267928A2 Methods for immunostimulation using bispecific binding agents for the fc receptor of immunoglobulin a and for cancer cells or infectious antigen |
| 01/02/2003 | EP1267925A1 Treatment of fungal infection with polyene or beta glucan synthase inhibitor antifungals combined with anti hsp90 antibodies |
| 01/02/2003 | EP1267924A2 Immunotherapeutic methods and compositions |
| 01/02/2003 | EP1267923A1 Use of aliphatic quaternary ammonium as adjuvant in a pharmaceutical composition administered by mucosal delivery |
| 01/02/2003 | EP1267922A1 Pneumococcus polysaccharide conjugates for use as vaccine against tetanus and diphtheria |
| 01/02/2003 | EP1267920A2 Cold-adapted equine influenza viruses |
| 01/02/2003 | EP1267919A2 A method for generating immunogens that elicit neutralizing antibodies against fusion-active regions of hiv envelope proteins |
| 01/02/2003 | EP1267918A1 Method of treatment using ligand-immunogen conjugates |
| 01/02/2003 | EP1267915A2 Methods of treating diseases with activated protein c |
| 01/02/2003 | EP1267899A2 Salmonella vaccine materials and methods |
| 01/02/2003 | EP1267898A2 Bile acid containing prodrugs with enhanced bioavailability |
| 01/02/2003 | EP1267895A1 Use of feracryl for the treatment of peptic/duodenal ulcer and/or cholera |
| 01/02/2003 | EP1267893A2 Immunostimulatory polynucleotide sequences for use in preventing and treating viral infections |
| 01/02/2003 | EP1267891A2 Antiadhesive carbohydrates |
| 01/02/2003 | EP1267880A1 Low dose entecavir formulation and use |
| 01/02/2003 | EP1267879A2 Sustained release beadlets containing stavudine |
| 01/02/2003 | EP1267858A2 Diphenyl ketoaldehyde derivatives with anti-hiv activity |
| 01/02/2003 | EP1267837A1 Matrices containing nitric oxide donors and reducing agents and their use |
| 01/02/2003 | EP1267835A1 D and l etherlipid stereoisomers and liposomes |
| 01/02/2003 | EP1267826A1 Pharmaceutical composition for treatment of mucosal epithelial ulceration and/or erosion |
| 01/02/2003 | EP1267765A1 Antibiotic and antifungal compositions |
| 01/02/2003 | EP1267626A1 Recombinant parainfluenza virus expression systems and vaccines |
| 01/02/2003 | EP1139755A4 Method for treatment of bacterial infections with once or twice-weekly administered rifalazil |
| 01/02/2003 | EP0992241B1 Medicinal compositions against helicobacter pylori |
| 01/02/2003 | EP0979284B1 Reagents for vaccination which generate a cd8 t cell immune response |
| 01/02/2003 | EP0806960B1 Extracts of shark cartilage, process of production and uses thereof |
| 01/02/2003 | EP0723440B1 Therapeutic delivery compositions and methods of use thereof |
| 01/01/2003 | CN1388807A Penicillin crystal and process for producing the same |
| 01/01/2003 | CN1388806A Crystals of penicillin and process for the production thereof |
| 01/01/2003 | CN1388758A Pharmaceutical compositions of anti-tubercular drugs and process for their preparation |
| 01/01/2003 | CN1388126A 吡咯并三嗪和嘧啶化合物 Pyrrolo-triazine and pyrimidine compounds |
| 01/01/2003 | CN1388120A Intermediate used as new industrial products in preparation of new cephalosporin containing sbstituted benzyloxy imino on 7-position |
| 01/01/2003 | CN1387894A Chinese herbal medicine for treating hepatitis A |
| 01/01/2003 | CN1387884A Chinese herbal medicine for treating No.5 disease of livestock |
| 01/01/2003 | CN1387865A Chinese medicine for treating pelvic infection and its production process |
| 01/01/2003 | CN1387860A Yunnan Heiyao and its application in treating viral, bacterial and fungal diseases |
| 01/01/2003 | CN1387855A Licorice polysaccharide powder injection |
| 01/01/2003 | CN1387853A Externally applied compound antifungal prepn |
| 01/01/2003 | CN1387844A Wide-spectrum externally applied venereal remedy |
| 01/01/2003 | CN1097468C Products containing G-CSF and TNF binding protein |
| 01/01/2003 | CN1097467C Vaccine compositions |